Hosted on MSN6h
Advanced Clinical chosen as CRO for Paradigm’s Phase III osteoarthritis trial
Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...
Hosted on MSN23h
Paradigm closer to phase III clinical trial with appointment of preferred CRO
Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III ...
appliedclinicaltrialsonline12d
Decentralized Phase I Trial Highlights Promise of Remote Data Collection to Improve Clinical Research
Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
PharmaTimes7d
Vedanta Biosciences reveals Phase 2 VE303 results
Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study for VE303, a potential first-in-class ...
Business Wire19d
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
The phase 3 pivotal safety study of oral weekly risperidone is planned to be initiated in 1H 2025. “Lyndra’s clinical research and manufacturing collaboration with Thermo Fisher is a critical ...